Register
FDA updates warnings for fluoroquinolones on risks of mental health and hypoglycemia |
Journal Updates
eMediNexus Coverage from: 
FDA updates warnings for fluoroquinolones on risks of mental health and hypoglycemia
eMediNexus,  11 July 2018
remove_red_eye 706 Views
#Pathology and Lab Medicine #Psychiatry #Public Health


comment                   
        



The US Food and Drug Administration (FDA) is requiring safety labeling changes for a class of antibiotics called fluoroquinolones to strengthen the warnings about the risks of mental health side effects and serious blood sugar disturbances, and make these warnings more consistent across the labeling for all fluoroquinolones taken by mouth or given by injection.


Comments

Comments on eMediNexus are moderated. We retain the right to remove any comments at our sole discretion.


  • Dr Kavita Saraf 12 July - 18:26 hrs

    Diabetic patient taking either OHA or on insulin, if by any chance given Fluroquinolones,chances of hypoglycemia is very high.

    • REPLY